JP2009517345A - 創傷治癒の方法 - Google Patents

創傷治癒の方法 Download PDF

Info

Publication number
JP2009517345A
JP2009517345A JP2008541550A JP2008541550A JP2009517345A JP 2009517345 A JP2009517345 A JP 2009517345A JP 2008541550 A JP2008541550 A JP 2008541550A JP 2008541550 A JP2008541550 A JP 2008541550A JP 2009517345 A JP2009517345 A JP 2009517345A
Authority
JP
Japan
Prior art keywords
euphorbia
wound
ingenol
subject
pep005
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008541550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009517345A5 (enExample
Inventor
スティーブン マーティン オグボーン
デイビッド トーマス
リアン モーズリー
Original Assignee
ペプリン リサーチ プロプライエタリー リミティッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005906601A external-priority patent/AU2005906601A0/en
Application filed by ペプリン リサーチ プロプライエタリー リミティッド filed Critical ペプリン リサーチ プロプライエタリー リミティッド
Publication of JP2009517345A publication Critical patent/JP2009517345A/ja
Publication of JP2009517345A5 publication Critical patent/JP2009517345A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2008541550A 2005-11-25 2006-11-24 創傷治癒の方法 Pending JP2009517345A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005906601A AU2005906601A0 (en) 2005-11-25 Therapeutic methods and compositions
PCT/AU2006/001781 WO2007059584A1 (en) 2005-11-25 2006-11-24 Methods for wound healing

Publications (2)

Publication Number Publication Date
JP2009517345A true JP2009517345A (ja) 2009-04-30
JP2009517345A5 JP2009517345A5 (enExample) 2009-12-17

Family

ID=38066849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008541550A Pending JP2009517345A (ja) 2005-11-25 2006-11-24 創傷治癒の方法

Country Status (9)

Country Link
US (2) US20090215884A1 (enExample)
EP (1) EP1965818A4 (enExample)
JP (1) JP2009517345A (enExample)
KR (1) KR20080077625A (enExample)
CN (1) CN101360506A (enExample)
BR (1) BRPI0618926A2 (enExample)
CA (1) CA2629899A1 (enExample)
NZ (1) NZ568168A (enExample)
WO (1) WO2007059584A1 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009242323A (ja) * 2008-03-31 2009-10-22 Naris Cosmetics Co Ltd ケラチノサイト増殖促進剤
JP2013525300A (ja) * 2010-04-16 2013-06-20 レオ ファーマ アクティーゼルスカブ 結晶性インゲノールメブテート
JP2013530224A (ja) * 2010-06-30 2013-07-25 エイボン プロダクツ インコーポレーテッド Ｍａｇｐ−１に刺激を与えて皮膚の外観を改善する組成物及び方法
JP2014507396A (ja) * 2010-12-22 2014-03-27 レオ・ラボラトリーズ・リミテッド イノゲノール−３−アシラートｉ
JP2014507393A (ja) * 2010-12-22 2014-03-27 レオ・ラボラトリーズ・リミテッド ３−アシル−イノゲノールｉｉ
JPWO2014104064A1 (ja) * 2012-12-26 2017-01-12 株式会社エーゼット 創傷治癒促進剤

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ801700A0 (en) 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
NZ583157A (en) 2004-12-13 2011-12-22 Leo Lab Ltd Treatment of solid cancers with angeloyl substituted ingenanes
PT2395993T (pt) * 2009-02-13 2017-07-18 Leo Laboratories Ltd Tratamento cutâneo
KR102499738B1 (ko) 2009-08-26 2023-02-13 마리 케이 인코포레이티드 식물 추출물을 포함하는 국소 피부 케어 제형
WO2012080466A2 (en) 2010-12-17 2012-06-21 Leo Pharma A/S Ingenols for treating seborrheic keratosis
JP5845283B2 (ja) * 2010-12-22 2016-01-20 レオ・ラボラトリーズ・リミテッドＬｅｏ Ｌａｂｏｒａｔｏｒｉｅｓ Ｌｉｍｉｔｅｄ インゲノール−３−アシラートｉｉｉおよびインゲノール−３−カルバメート
WO2012176015A1 (en) * 2011-06-24 2012-12-27 Leo Pharma A/S Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
GB201110777D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
EP2790669A1 (en) * 2011-12-12 2014-10-22 Leo Laboratories Limited A topical composition comprising an ingenol derivative and an oily solvent
US20130251782A1 (en) * 2012-03-22 2013-09-26 Leo Laboratories Limited Topical application of ingenol mebutate with occlusion
MX2014015497A (es) * 2012-06-26 2015-03-06 Leo Lab Ltd 3-o-heteroaril-ingenol.
KR20150027831A (ko) * 2012-07-06 2015-03-12 레오 파마 에이/에스 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물
WO2014158858A1 (en) * 2013-03-13 2014-10-02 Avon Products, Inc Glochidium wallichianum extracts and methods of use
CN105055448A (zh) * 2015-05-25 2015-11-18 中国人民解放军第三军医大学第一附属医院 铜离子制剂在制备促进皮肤角质形成细胞增殖药物或敷料中的用途
US20190192636A1 (en) * 2016-03-18 2019-06-27 Intrexon Corporation Compositions and methods for treatment of type viii collagen deficiencies
CN106619600B (zh) * 2016-03-28 2019-10-18 中国科学院遗传与发育生物学研究所 巨大戟醇及其衍生物在增强溶酶体生成中的应用
CN115677520B (zh) * 2022-11-18 2024-04-02 扬州大学 一种二萜化合物及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002535138A (ja) * 1999-01-29 2002-10-22 シデ ソシエテ インダストリエーレ ド ラ ドゥ エス アー 少なくとも１個の回転軸を備えた粉砕装置
JP2003506488A (ja) * 1999-08-13 2003-02-18 フォトゲン インク 疾患の光線力学的療法のための改良された局所用薬品および方法
JP2003535136A (ja) * 2000-06-07 2003-11-25 ペプリン リサーチ プロプライエタリー リミティッド 治療効果のある物質−ｉｉｉ

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809749A (en) * 1971-03-05 1974-05-07 Amazon Natural Drug Co Topical pharmaceutical composition and method employing sap from the tree croton lechleri
DE2902506A1 (de) * 1979-01-23 1980-07-24 Deutsches Krebsforsch Verwendung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon als antineoplastische mittel
US4418064A (en) * 1982-09-29 1983-11-29 The United States Of America As Represented By The Secretary Of Agriculture Chemotherapeutically active maytansinoids: treflorine, trenudine, and N-methyltrenudone
US4560774A (en) * 1982-11-17 1985-12-24 Arizona State University Macrocyclic lactones
US5886019A (en) * 1986-06-11 1999-03-23 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. F.
US5962498A (en) * 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US5891870A (en) * 1986-06-11 1999-04-06 Procyon Pharmaceuticals, Inc. Protein kinase C modulators Q
US5891906A (en) * 1986-06-11 1999-04-06 Procyon Pharmaceuticals, Inc. Polyacetate-derived phorboids having anti-inflammatory and other uses
US5643948A (en) * 1986-06-11 1997-07-01 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. K.
US5886017A (en) * 1986-06-11 1999-03-23 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. E.
US5750568A (en) * 1986-06-11 1998-05-12 Procyon Pharmaceuticals, Inc. Protein kinase C Modulators. L.
US5716968A (en) * 1986-06-11 1998-02-10 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. H.
US5145842A (en) * 1986-06-11 1992-09-08 Alder Research Center Limited Partnership Protein kinase c. modulators. d.
DE4102054A1 (de) * 1991-01-24 1992-07-30 Geb Szenasi Tamas Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5317009A (en) * 1991-08-26 1994-05-31 New York University Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
US6593371B1 (en) * 1993-05-19 2003-07-15 Jeff J. Staggs Treatment for wart and related disorders
US5874464A (en) * 1995-01-13 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Conformationally constrained diacylglycerol analogues
US5932613A (en) * 1996-07-03 1999-08-03 Millennium Pharmaceuticals, Inc. Anticancer agents
AUPO864097A0 (en) * 1997-08-19 1997-09-11 Peplin Pty Ltd Anti-cancer compounds
JP2001139468A (ja) * 1999-11-11 2001-05-22 Lead Chemical Co Ltd 抗ウイルス作用を有するホルボール誘導体
AUPQ923100A0 (en) * 2000-08-07 2000-08-31 Peplin Research Pty Ltd Treatment of prostate cancer
US6923993B2 (en) * 2001-12-12 2005-08-02 Nicholas J. Donato Process of isolating extract from the Euphorbia obesa plant and methods for using the same
US7390499B2 (en) * 2002-04-26 2008-06-24 Lohmann & Rauscher Gmbh Microbial cellulose wound dressing for treating chronic wounds
WO2005043155A1 (en) * 2003-10-21 2005-05-12 Cedars-Sinai Medical Center System and method for the treatment of cancer, including cancers of the central nervous system
CA2552411A1 (en) * 2004-01-01 2005-07-21 Panacea Biotec Ltd. Pharmaceutical compositions comprising an extract of euphorbia prostrata
BRPI0504797B1 (pt) * 2005-10-27 2020-02-04 Pele Nova Biotecnologia S.A. formulação tópica, método de tratamento cosmético para rejuvenescimento da pele, método de tratamento cosmético e uso de uma formulação

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002535138A (ja) * 1999-01-29 2002-10-22 シデ ソシエテ インダストリエーレ ド ラ ドゥ エス アー 少なくとも１個の回転軸を備えた粉砕装置
JP2003506488A (ja) * 1999-08-13 2003-02-18 フォトゲン インク 疾患の光線力学的療法のための改良された局所用薬品および方法
JP2003535136A (ja) * 2000-06-07 2003-11-25 ペプリン リサーチ プロプライエタリー リミティッド 治療効果のある物質−ｉｉｉ
JP2003535137A (ja) * 2000-06-07 2003-11-25 ペプリン リサーチ プロプライエタリー リミティッド 治療効果のある物質−ｉ

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN7012002029; Ｐ．　Ｈａｍｐｓｏｎ　ｅｔ．ａｌ．: '"ＰＥＰ-００５　Ｔｒｅａｔｍｅｎｔ　ｏｆ　Ａｃｔｉｎｉｃ　Ｋｅｒａｔｏｓｅｓ　Ａｃｕｔｅ　Ｍｙｅｌｏｉｄ　Ｌｅｕｋｅｍｉａ　Ｔｈｅｒａｐｙ　Ｔｒｅａｔｍｅｎｔ　ｏｆ　Ｂａｓａｌ　Ｃｅｌｌ　Ｃａｒｃｉ' Ｄｒｕｇｓ　ｏｆ　ｔｈｅ　Ｆｕｔｕｒｅ Ｖｏｌ．３０，　Ｎｏ．１０, 2005, ｐ．１００３-１００５ *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009242323A (ja) * 2008-03-31 2009-10-22 Naris Cosmetics Co Ltd ケラチノサイト増殖促進剤
JP2013525300A (ja) * 2010-04-16 2013-06-20 レオ ファーマ アクティーゼルスカブ 結晶性インゲノールメブテート
JP2013530224A (ja) * 2010-06-30 2013-07-25 エイボン プロダクツ インコーポレーテッド Ｍａｇｐ−１に刺激を与えて皮膚の外観を改善する組成物及び方法
JP2014507396A (ja) * 2010-12-22 2014-03-27 レオ・ラボラトリーズ・リミテッド イノゲノール−３−アシラートｉ
JP2014507393A (ja) * 2010-12-22 2014-03-27 レオ・ラボラトリーズ・リミテッド ３−アシル−イノゲノールｉｉ
JPWO2014104064A1 (ja) * 2012-12-26 2017-01-12 株式会社エーゼット 創傷治癒促進剤
US9962364B2 (en) 2012-12-26 2018-05-08 A-Z Ltd. Wound healing accelerator

Also Published As

Publication number Publication date
NZ568168A (en) 2012-06-29
BRPI0618926A2 (pt) 2011-09-13
EP1965818A1 (en) 2008-09-10
KR20080077625A (ko) 2008-08-25
CN101360506A (zh) 2009-02-04
WO2007059584A1 (en) 2007-05-31
US20160317486A1 (en) 2016-11-03
EP1965818A4 (en) 2010-02-17
US20090215884A1 (en) 2009-08-27
CA2629899A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
US20160317486A1 (en) Method for wound healing
RU2506951C2 (ru) Лечение повреждений, индуцированных вирусом
Xie et al. Gastroprotective effect of gamma-aminobutyric acid against ethanol-induced gastric mucosal injury
Chen et al. A pirfenidone loaded spray dressing based on lyotropic liquid crystals for deep partial thickness burn treatment: healing promotion and scar prophylaxis
JP6239041B2 (ja) 微生物感染の治療に使用するためのタマリンド種子多糖
JP2012517450A (ja) 皮膚治療方法
Li et al. Evaluation of efficacy of aloin in treating acute trauma in vitro and in vivo
ES2467668T3 (es) Composicón farmaceutica, vendaje y método para tratar lesión cutánea, composición intermedia y proceso para preparar dicho vendaje y uso de sal de cerio asociada con una matriz de colágeno
Getahun et al. In vivo evaluation of 80% methanolic leaves crude extract and solvent fractions of buddleja polystachya fresen (buddlejaceae) for wound healing activity in normal and diabetic mice
JP2013060455A (ja) ハチ毒を有効成分とする組成物
KR102026409B1 (ko) 유근피 또는 유백피 파우더를 유효성분으로 포함하는 창상 치료 및 피부 재생용 조성물
Rahayu et al. Effectiveness of black soldier fly (Hermetia illucens) prepupa oil emulgel for burn wound recovery
KR101799300B1 (ko) Ｃｌａｓｐ２를 이용한 상처 치유 또는 피부 재생용 조성물
TWI288646B (en) Novel dressing materials capable of promoting rapid healing of wounded skin surfaces
Hapsari et al. Burn healing with binahong (Anredera cordifolia (Tenore) Steenis) leaves extract as a topical and systemic treatments
EP2070531A1 (en) Pharmaceutical preparation containing histamine H2-receptor antagonists having wound healing activity at low doses
EP1434591A1 (de) Verwendung von fliegenlarvenextrakten zur wundbehandlung
DE102006038252A1 (de) Zubereitung mit marinem Kollagen zur Proteinasehemmung
AU2006317523A1 (en) Methods for wound healing
OD et al. Healing Potentials of Nigerian Bee Propolis on Meticillin-Resistant Staphylococcus Aureus Infected Skin Wound of Wistar Rats.
US11439655B2 (en) Compounds for use in wound healing and angiogenesis
KR101819368B1 (ko) 트랜스젤린 재조합 단백질을 이용한 상처 치유 또는 피부 재생용 조성물
JP2023504880A (ja) 慢性創傷治癒組成物およびその適用
RU2731175C1 (ru) Мазь для лечения ожогов 1-3 степени
KR100918475B1 (ko) 퍼옥시좀 증식활성화 수용체 델타에 특이적인 리간드를 포함하는 피부 외용제 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091027

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120530

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120829

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120905

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130311